196 related articles for article (PubMed ID: 33757442)
1. Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study.
Lv Z; Liang Y; Liu H; Mo D
BMC Cancer; 2021 Mar; 21(1):306. PubMed ID: 33757442
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study.
Liu LL; Xiang ZL
Therap Adv Gastroenterol; 2022; 15():17562848221137758. PubMed ID: 36458048
[TBL] [Abstract][Full Text] [Related]
3. Competing nomograms help in the selection of elderly patients with colon cancer for adjuvant chemotherapy.
Li D; Zhong C; Tang X; Yu L; Ding K; Yuan Y
J Cancer Res Clin Oncol; 2018 May; 144(5):909-923. PubMed ID: 29460089
[TBL] [Abstract][Full Text] [Related]
4. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.
Ackermann CJ; Guller U; Jochum W; Schmied BM; Warschkow R
Int J Colorectal Dis; 2018 Sep; 33(9):1183-1193. PubMed ID: 29881972
[TBL] [Abstract][Full Text] [Related]
6. Nomogram predicting cancer-specific survival in elderly patients with stages I-III colon cancer.
Zheng P; Lai C; Yang W; Guo J; Xiao S; Chen Z
Scand J Gastroenterol; 2020 Feb; 55(2):202-208. PubMed ID: 32008420
[No Abstract] [Full Text] [Related]
7. Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer.
Lee KY; Park JW; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
Sci Rep; 2019 Aug; 9(1):11846. PubMed ID: 31413354
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study.
Zheng P; Chen Q; Li J; Jin C; Kang L; Chen D
J Surg Res; 2020 Jan; 245():475-482. PubMed ID: 31446189
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy with tegafur/uracil for more than 1 year improves disease-free survival for low-risk Stage II colon cancer.
Hu JM; Chou YC; Wu CC; Hsiao CW; Lee CC; Chen CT; Hu SI; Liu WT; Jao SW
J Chin Med Assoc; 2016 Sep; 79(9):477-88. PubMed ID: 27329402
[TBL] [Abstract][Full Text] [Related]
10. Effect of Chemotherapy in Stage II-IV Large-Cell Lung Carcinoma and Construction of Its Predictive Nomograms: A SEER Analysis.
Hu G; Liu Y; Li X; Jin M; Liu X; Yu Q
Med Princ Pract; 2023; 32(1):49-60. PubMed ID: 36652925
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a prognostic nomogram for early-onset colon cancer.
Yu C; Zhang Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142625
[TBL] [Abstract][Full Text] [Related]
12. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
13. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
[TBL] [Abstract][Full Text] [Related]
14. Effects of Adjuvant Chemotherapy on Early-onset Stage II Colon Cancer at Different Tumor Sites.
Tan C; Wang Q; Yao S
Am J Clin Oncol; 2024 Jun; 47(6):253-258. PubMed ID: 38251762
[TBL] [Abstract][Full Text] [Related]
15. Prognostic model for predicting the survival benefit of adjuvant chemotherapy for elderly patients with stage II colon cancer: a population-based study.
Yu G; Wei R; Liu H; Liu Y; Guan X; Wang X; Jiang Z
Eur J Cancer Prev; 2024 Mar; 33(2):105-114. PubMed ID: 38299664
[TBL] [Abstract][Full Text] [Related]
16. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
[TBL] [Abstract][Full Text] [Related]
17. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
[TBL] [Abstract][Full Text] [Related]
18. Nomograms predict survival benefits of radical prostatectomy and chemotherapy for prostate cancer with bone metastases: A SEER-based study.
Sun D; Lin A; Sun Z; Yang S; Sun Y; Chen A; Qian G; Ji Z; Wang L
Front Oncol; 2022; 12():1020898. PubMed ID: 36561516
[TBL] [Abstract][Full Text] [Related]
19. Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study.
Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
J Natl Compr Canc Netw; 2016 Jan; 14(1):47-56. PubMed ID: 26733554
[TBL] [Abstract][Full Text] [Related]
20. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
Ejaz A; Casadaban L; Maker AV
J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
